Clinical Trial Update: Efficacy and Safety of Sirolimus Plus CNI Compared With MMF Plus CNI in ABO-i Kidney Transplant Recipients. [Phase 4]

View source ↗

Summary

Phase 4 trial comparing sirolimus plus calcineurin inhibitor versus mycophenolate plus calcineurin inhibitor in ABO-incompatible kidney transplant recipients, a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplantation

Drugs mentioned

• Calcineurin inhibitor (calcineurin inhibitor)
• MYCOPHENOLATE MOFETIL (MYCOPHENOLATE MOFETIL)
• Sirolimus (Sirolimus)

Snippet

Sponsor: Chong Kun Dang Pharmaceutical | Conditions: Kidney Transplantation | Phase 4 | Status: UNKNOWN